Activation of macrophage tumoricidal activity by photodynamic treatment in vitro - Indirect activation of macrophages by photodynamically killed tumor cells

Journal of Photochemistry and Photobiology B: Biology

Volumn 50, Issue 2-3, 1999, Pages 99-107

  Reiter, Isabella ^a   Schwamberger, Günter ^b   Krammer, Barbara ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

Cytotoxicity; Macrophages; Nitric oxide; Oxidative stress; Photosensitizer; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; HEMATOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CYTOTOXICITY; EFFECTOR CELL; FEMALE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; TUMOR CELL DESTRUCTION;

ANIMALS; BONE MARROW CELLS; CELL SURVIVAL; CELLS, CULTURED; FEMALE; HEMATOPORPHYRINS; INTERFERON-GAMMA, RECOMBINANT; LYMPHOMA, T-CELL; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032853166     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(99)00078-0     Document Type: Article

References (47)

1. [1] T.J. Dougherty, Yearly review: photodynamic therapy, Photochem. Photobiol. 58 (1993) 895-900.
2. [2] B.W. Henderson, T.J. Dougherty, How does photodynamic therapy work?, Photochem. Photobiol. 55 (1992) 145-157.
3. [3] H.I. Pass, Photodynamic therapy in oncology: mechanisms and clinical use, J. Natl. Cancer Inst. 85 (1993) 443-456.
4. [4] J.S. Nelson, L.H. Liaw, M.W. Berns, Tumor destruction in photodynamic therapy, Photochem. Photobiol. 46 (1987) 829-835.
5. [5] M. Oschner, Photophysical and photobiological processes in the photodynamic therapy of tumors, J. Photochem. Photobiol. B: Biol. 39 (1997) 1-18.
6. [6] J. Moan, K. Berg, Yearly review: photochemotherapy of cancer: experimental research, Photochem. Photobiol. 55 (1992) 931-948.
7. [7] M. Korbelik, G. Krosl, J. Krosl, G.J. Dougherty, The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy, Cancer Res. 56 (1996) 5647-5652.
8. [8] I.J. Fidler, A.J. Schroit, Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self, Biochim. Biophys. Acta 948 (1988) 151-173.
9. [9] G. Canti, D. Lattuada, A. Nicolin, P. Taroni, G. Valentini, R. Cebeddu, Immunopharmacology studies on photosensitizers used in photodynamic therapy (PDT), SPIE Proc. 2078 (1994) 268-275.
10. [10] M. Korbelik, Induction of tumor immunity by photodynamic therapy, J. Clin. Laser Med. Surg. 14 (1996) 329-334.
11. [11] C.D. Elmets, K.D. Bowen, Immunological suppression in mice treated with hematoporphyrin derivative photoradiation, Cancer Res. 46 (1986) 1608-1611.
12. [12] C.J. Jolles, M.J. Ott, R.C. Straight, D.H. Lynch, Systematic immunosuppression induced by peritoneal photodynamic therapy, Am. J. Obst. Gyn. 158 (1988) 1446.
13. [13] D.H. Lynch, S. Haddad, V.J. King, M.J. Ott, R.C. Straight, C.J. Jolles, Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages, Photochem. Photobiol. 49 (1989) 453-458.
14. [14] J.F. Marshall, W.S. Chan, I.R. Hart, Effect of photodynamic therapy on anti-tumor immune defenses: comparison of the photosensitizers hematoporphyrin derivative and chloro-aluminum sulfonated phthalocyanine, Photochem. Photobiol. 49 (1989) 627-632.
15. [15] N. Yamamoto, S. Homma, T.W. Sery, L.A. Donoso, J.K. Hoober, Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light, Eur. J. Cancer 27 (1991) 467-471.
16. [16] S. Evans, W. Matthews, R. Perry, D. Fraker, J. Norton, H.I. Pass, Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages, J. Natl. Cancer Inst. 82 (1990) 34-39.
17. [17] I. Reiter, G. Schwamberger, B. Krammer, Effect of photodynamic pretreatment on the susceptibility of murine tumor cells to macrophage antitumor mechanisms, Photochem. Photobiol. 66 (1997) 384-388.
18. [18] I. Flesch, E. Ferber, Growth requirements of murine bone marrow macrophages in serum-free cell culture, Immunobiology 171 (1986) 14-26.
19. [19] J.W.M. van der Meer, J.S. van der Gevel, M.M.C. Diesselhoff-den Dulk, R.H.J. Beelen, R. van Furth, in: R. van Furth (Ed.), Mononuclear Phagocytes. Functional Aspects, Martinus Nijhof, Boston, 1980, pp. 343-361.
20. [20] P.J.M. Leenen, M.F.T.R. de Bruijn, J.S.A. Voerman, P.A. Campbell, W. van Ewijk, Markers of mouse macrophage development detected by monoclonal antibodies, J. Immunol. Methods 174 (1994) 5-19.
21. [21] M. Modolell, P.G. Munder, Macrophage mediated tumor cell destruction measured by an alkaline phosphatase assay, J. Immunol. Methods 174 (1994) 203-208.
22. [22] T. Decker, M.L. Lohmann-Matthes, A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity, J. Immunol. Methods 115 (1988) 61-69.
23. [23] G. Schwamberger, I. Flesch, E. Ferber, Characterization and partial purification of a high molecular weight tumoricidal activity secreted by murine bone marrow macrophages, Int. Immunol. 4 (1992) 253-264.
24. [24] T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55-63.
25. [25] A.H. Ding, C.F. Nathan, D.J. Stuehr, Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages, J. Immunol. 141 (1988) 2407-2412.
26. [26] P. Griess, 'Bermerkungen zu der Abhandlung der Herren Weselsky und Benedikt' Ueber einige Azoverbindungen, Ber. Deutsch. Chem. Ges. 12 (1879) 426-428.
27. [27] I. Minkenberg, E. Ferber, Lucigenin-dependent chemiluminescence as a new assay for NAD(P) H-oxidase activity in particulate fractions of human polymorphonuclear leukocytes, J. Immunol. Methods 71 (1984) 61-67.
28. [28] G. Schwamberger, I. Flesch, E. Ferber, Tumoricidal effector molecules of murine macrophages, Pathobiology 59 (1991) 248-253.
29. [29] J.M. Mueller, H.W. Lörns Ziegler-Hettbrock, P.A. Baeuerle, Nuclear factor kappa B, a mediator of lipopolysaccharide effects, Immunobiology 187 (1993) 233-256.
30. [30] P.A. Baeuerle, T. Henkel, Function and activation of NF-κB in the immune system, Annu. Rev. Immunol. 12 (1994) 141-179.
31. [31] R.W. Steubing, S. Yeturu, A. Tuccillo, C.H. Sun, M.W. Berns, Activation of macrophages by Photofrin II during photodynamic therapy, J. Photochem. Photobiol. B: Biol. 10 (1991) 133-145.
32. [32] N. Yamamoto, J.K. Hoober, N. Yamamoto, S. Yamamoto, Tumoricidal capacities of macrophages photodynamically activated with hematoporphyrin derivative, Photochem. Photobiol. 56 (1992) 245-250.
33. [33] N. Yamamoto, T.W. Sery, J.K. Hoober, N.P. Willett, D.D. Lindsay, Effectiveness of photofrin II in activation of macrophages and in vitro killing of retinoblastoma cells, Photochem. Photobiol. 60 (1994) 160-164.
34. [34] R. Schreck, P. Rieber, P.A. Baeuerle, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1, EMBO J. 10 (1991) 2247-2258.
35. [35] A. Mantovani, B. Bottazzi, F. Colotta, S. Sozzani, L. Ruco, The origin and function of tumor-associated macrophages, Immunol. Today 13 (1992) 265-270.
36. [36] R.B. Johnston, Monocytes and macrophages, N. Engl. J. Med. 318 (1988) 747-752.
37. [37] Y. Sibille, H.Y. Reynolds, Macrophages and polymorphonuclear neutrophils in lung defense and injury, Am. Rev. Respir. Dis. 141 (1990) 471-501.
38. [38] D.O. Adams, T.A. Hamilton, The cell biology of macrophage activation, Annu. Rev. Immunol. 2 (1984) 283-318.
39. [39] M.S. Patterson, S.J. Madson, B.C. Wilson, Experimental tests of the feasibility of singlet oxygen luminescence monitoring in vivo during photodynamic therapy, J. Photochem. Photobiol. B: Biol. 5 (1990) 69-84.
40. [40] J.L. Urban, H.M. Shepard, J.L. Rothstein, B.J. Sugarman, H. Schreiber, Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages, Proc. Natl. Acad. Sci. USA 83 (1986) 5233-5237.
41. [41] A. Asher, J.J. Mule, C.M. Reichert, Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo, J. Immunol. 138 (1987) 963-974.
42. [42] I. Flesch, A. Früh, E. Ferber, Functional comparison of bone marrow-derived macrophages obtained by cultivation in serum-free or serum-supplemented medium, Immunobiology 173 (1986) 72-81.
43. [43] G. Kick, G. Messer, A. Goetz, G. Plewig, P. Kind, Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding, Cancer Res. 55 (1995) 2373-2379.
44. [44] M. Korbelik, J. Hung, Cellular delivery and retention of Photofrin II: the effects of interaction with human plasma proteins, Photochem. Photobiol. 53 (1990) 501-510.
45. [45] J-D. Hasday, E.K. Crawford, Effects of assay medium composition on macrophage-mediated tumor cell binding and lysis, J. Immunol. Methods 114 (1988) 243-252.
46. [46] M. Korbelik, G. Krosl, D.J. Chaplin, Photofrin uptake by murine macrophages, Cancer Res. 51 (1991) 2251-2255.
47. [47] S.A. Eccles, P. Alexander, Macrophage content of tumors in relation to metastatic spread and host immune reaction, Nature 250 (1974) 667-669.